XTX Topco Ltd Purchases New Position in The Pennant Group, Inc. (NASDAQ:PNTG)

XTX Topco Ltd purchased a new stake in The Pennant Group, Inc. (NASDAQ:PNTGFree Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 11,343 shares of the company’s stock, valued at approximately $285,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. FMR LLC boosted its holdings in shares of The Pennant Group by 54.5% during the 4th quarter. FMR LLC now owns 3,906,327 shares of the company’s stock worth $103,596,000 after purchasing an additional 1,377,815 shares during the last quarter. Van Berkom & Associates Inc. boosted its holdings in shares of The Pennant Group by 29.6% during the 1st quarter. Van Berkom & Associates Inc. now owns 2,849,562 shares of the company’s stock worth $71,666,000 after purchasing an additional 651,346 shares during the last quarter. Millennium Management LLC boosted its holdings in shares of The Pennant Group by 1,274.9% during the 4th quarter. Millennium Management LLC now owns 181,767 shares of the company’s stock worth $4,820,000 after purchasing an additional 168,547 shares during the last quarter. Zimmer Partners LP acquired a new position in shares of The Pennant Group during the 4th quarter worth approximately $3,978,000. Finally, Nuveen Asset Management LLC boosted its holdings in shares of The Pennant Group by 29.7% during the 4th quarter. Nuveen Asset Management LLC now owns 457,364 shares of the company’s stock worth $12,129,000 after purchasing an additional 104,697 shares during the last quarter. Hedge funds and other institutional investors own 85.88% of the company’s stock.

The Pennant Group Price Performance

Shares of NASDAQ:PNTG opened at $26.00 on Monday. The company has a quick ratio of 1.21, a current ratio of 1.21 and a debt-to-equity ratio of 0.11. The company has a market cap of $898.56 million, a P/E ratio of 33.33, a PEG ratio of 2.21 and a beta of 1.48. The Pennant Group, Inc. has a 52 week low of $21.18 and a 52 week high of $37.13. The company has a 50-day moving average price of $26.04 and a 200 day moving average price of $26.00.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Wells Fargo & Company upped their price objective on The Pennant Group from $30.00 to $31.00 and gave the company an “equal weight” rating in a report on Tuesday, June 3rd. Wall Street Zen upgraded The Pennant Group from a “hold” rating to a “buy” rating in a report on Saturday. Truist Financial decreased their price objective on The Pennant Group from $32.00 to $28.00 and set a “hold” rating on the stock in a report on Wednesday, July 16th. Finally, Stephens reiterated an “overweight” rating and issued a $35.00 price objective on shares of The Pennant Group in a report on Tuesday, June 10th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, The Pennant Group currently has an average rating of “Moderate Buy” and an average target price of $33.80.

View Our Latest Stock Analysis on The Pennant Group

Insider Buying and Selling at The Pennant Group

In other The Pennant Group news, Director Joanne Stringfield sold 5,000 shares of The Pennant Group stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $29.47, for a total value of $147,350.00. Following the completion of the sale, the director directly owned 30,275 shares of the company’s stock, valued at approximately $892,204.25. The trade was a 14.17% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 5.40% of the stock is currently owned by company insiders.

The Pennant Group Company Profile

(Free Report)

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.

Recommended Stories

Want to see what other hedge funds are holding PNTG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Pennant Group, Inc. (NASDAQ:PNTGFree Report).

Institutional Ownership by Quarter for The Pennant Group (NASDAQ:PNTG)

Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.